bms204352 has been researched along with Ataxia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahring, PK; Brown, WD; Hartz, BP; Korsgaard, MP; Mirza, NR; Strøbaek, D | 1 |
1 other study(ies) available for bms204352 and Ataxia
Article | Year |
---|---|
Anxiolytic effects of Maxipost (BMS-204352) and retigabine via activation of neuronal Kv7 channels.
Topics: Algorithms; Animals; Anti-Anxiety Agents; Anxiety; Ataxia; Behavior, Animal; Carbamates; Cell Line; Dose-Response Relationship, Drug; Emotions; Exploratory Behavior; Female; Hand Strength; Indoles; KCNQ Potassium Channels; KCNQ1 Potassium Channel; Male; Membrane Potentials; Mice; Neurons; Oocytes; Patch-Clamp Techniques; Phenylenediamines; Potassium Channels, Voltage-Gated; Rats; Rats, Wistar; Receptors, GABA-A; RNA, Complementary; Stereoisomerism; Xenopus laevis | 2005 |